2018 PharmaVOICE 100 – Rami Levin, President, North America, Sobi
In this blog post, we’ll share some highlights about Rami Levin, and see some of the reasons why he was honored in this year’s PharmaVOICE 100. You can also read his full profile here.
- Since being named president of Sobi North America in 2014, Rami Levin has built the company into a team of nearly 70 employees and brought important medicines to patients
- Rami led the company’s efforts to get HT-1 added to newborn screening in all 50 states, and launch a patient-support program to help patients and caregivers by providing access to nurse advisors, help navigating insurance and financial needs, developing low-protein recipes and meal-planning tools, and much more.
- Rami has also led Sobi in gaining FDA approval for Kineret (anakinra) for the potentially life-threatening rare genetic disease neonatal onset multisystem inflammatory disease (NOMID).
- Rami works to recruit the best talent, to build Sobi’s footprint, to break down barriers to access, and to find new ways the organization can support patients and caregivers.
- In addition to opening the Waltham location, Rami was instrumental in establishing a Canadian affiliate, and built all of the key functions needed in a pharmaceutical company, including sales, marketing, medical, operations and access, HR, legal, regulatory, finance, and communications.
- Spending his formative years as a competitive swimmer and later in the Israel defense force, he learned firsthand the importance of persistence, determination, and finding that balance between the heart and the mind, the place where passion and reason intersect.
“I would like to be remembered for my ability to bring together the best people, in the right environments, to help meet the changing needs of those who are living with rare diseases,” Rami says. “I don’t just mean by exploring treatment and delivery options, but also by creating tailored programming and communities where patients and families feel supported, informed, and empowered, despite the challenges they face.”